The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Toptas, TAYFUN; Pestereli, Elif; ŞİMŞEK, TAYUP; Bozkurt, SELEN; ERDOĞAN, GÜLGÜN; Karaveli, Seyda

doi:10.4103/0973-1482.172130

The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Toptas T., Pestereli E., ŞİMŞEK T., Bozkurt S., ERDOĞAN G., Karaveli S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.14, sa.3, ss.587-592, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14 Sayı: 3
Basım Tarihi: 2018
Doi Numarası: 10.4103/0973-1482.172130
Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.587-592
Anahtar Kelimeler: High-grade serous carcinoma, serous tubal intraepithelial carcinoma, survival, PROPHYLACTIC OOPHORECTOMY SPECIMENS, CANCER, ADENOCARCINOMA, FIMBRIA, TUMORS, WOMEN, P53
Akdeniz Üniversitesi Adresli: Evet

Özet

Aims: To investigate whether the presence of serous tubal intraepithelial carcinoma (STIC) is associated with clinical outcomes in a nonselected (unknown BRCA status) cohort of patients with a high-grade serous carcinoma (HGSC) of the ovary, fallopian tube, and peritoneum.